A pre-clinical analysis of immunohistochemistry for bone regeneration and angiogenesis with nanocomposite gels - A systematic review and meta-analysis.

BoneJul 8, 2026 (epub)
Clinical ResearchOrthopedic Surgery

Manju Philip, Sona Ann Roby, Ramya Ramadoss et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the effectiveness of nanocomposite gel scaffolds for bone regeneration and angiogenesis in pre-clinical studies. The analysis included 25 articles and found a significant improvement in bone regeneration outcomes, with a pooled standardized mean difference of 4.52 (95% CI [3.29, 5.75]) favoring the experimental group.

Key findings

  • The pooled standardized mean difference for bone regeneration was 4.52 (95% CI [3.29, 5.75]).
  • Twenty-five articles were included in the quantitative analysis.
  • The study highlights the broad applicability of nanocomposite gels across different animal models.

Why it matters

Understanding the potential of nanocomposite gels in bone regeneration can inform future surgical techniques and materials used in orthopedic and maxillofacial procedures, potentially improving patient outcomes.

Source

Published in Bone. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Orthopedic Surgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.